Grant Of Authority For Subzone Status, Ortho Biologics, LLC, (Pharmaceutical Intermediates), Manatí, Puerto Rico, 48537 [05-16401]

Download as PDF Federal Register / Vol. 70, No. 159 / Thursday, August 18, 2005 / Notices acres) located at 3309 Avenida Santiago de los Caballeros, Ponce; Site 2 (191 acres, 5 parcels)-Peerless Oil & Chemicals, Inc., petroleum terminal facilities located at Rt. 127, Km. 17.1, Penuelas; Site 3 (13 acres, 2 parcels)-Rio Piedras Distribution Center located within the central portion of the Quebrada Arena Industrial Park, and the Hato Rey Distribution Center located within the northeastern portion of the Tres Monjitas Industrial Park, San Juan; Site 4 (14 acres)-warehouse facility located at State Road No. 3, Km. 1401, Guayama (expires 10/1/04); Site 5 (256 acres, 34 parcels)-Mercedita Industrial Park located at the intersection of Route PR–9 and Las Americas Highway, Ponce; and, Site 6 (86 acres)-Coto Laurel Industrial Park located at the southwest corner of the intersection of Highways PR–56 and PR–52, Ponce. The sites are principally owned by the Port of Ponce, Vassallo Industries, Inc., and Desarrollos E Inversiones Del Sur, Inc. The applicant is requesting authority to expand the zone to include an ˜ additional site in Catano, located 5 miles from San Juan: Proposed Site 7 (7 acres)-industrial park, State Road 869, at ˜ Barrio Las Palmas, Catano. The site is principally owned by Able Sales, Inc. CODEZOL is requesting FTZ status for this site as part of FTZ 163 because the proposed site is related to existing activity at FTZ 163 (Site 1). No specific manufacturing requests are being made at this time. Such requests would be made to the Board on a case–by-case basis. In accordance with the Board’s regulations, a member of the FTZ Staff has been designated examiner to investigate the application and report to the Board. Public comment on the application is invited from interested parties. Submissions (original and 3 copies) shall be addressed to the Board’s Executive Secretary at one of the following addresses below: 1. Submissions via Express/Package Delivery Services: Foreign–Trade Zones Board, U.S. Department of Commerce, Franklin Court Building–Suite 4100W, 1099 14th Street, NW, Washington, DC 20005; or 2. Submissions via U.S. Postal Service: Foreign–Trade Zones Board, U.S. Department of Commerce, FCB– 4100W, 1401 Constitution Ave., NW, Washington, DC 20230. The closing period for their receipt is October 17, 2005. Rebuttal comments in response to material submitted during the foregoing period may be submitted during the subsequent 15-day period (to November 1, 2005). VerDate jul<14>2003 12:20 Aug 17, 2005 Jkt 205001 48537 A copy of the application will be available for public inspection at the Office of the Foreign–Trade Zones Board’s Executive Secretary at address No. 1 listed above and CODEZOL, C.D., 3309 Avenida Santiago de los Caballeros, Ponce, Puerto Rico 00734. intermediates at the manufacturing plant of Ortho Biologics, LLC, located in ´ Manatı, Puerto Rico (Subzone 7H), as described in the application and Federal Register notice, and subject to the FTZ Act and the Board’s regulations, including § 400.28. Dated: August 9, 2005. Dennis Puccinelli, Executive Secretary. [FR Doc. 05–16396 Filed 8–17–05; 8:45 am] Signed at Washington, DC, this 4th day of August 2005. BILLING CODE 3510–DS–S DEPARTMENT OF COMMERCE Foreign–Trade Zones Board [Order No. 1405] BILLING CODE 3510–DS–S Grant Of Authority For Subzone Status, Ortho Biologics, LLC, (Pharmaceutical Intermediates), ´ Manatı, Puerto Rico Pursuant to its authority under the Foreign–Trade Zones Act of June 18, 1934, as amended (19 U.S.C. 81a–81u), the Foreign– Trade Zones Board (the Board) adopts the following Order: Whereas, the Foreign–Trade Zones Act provides for ‘‘. . . the establishment . . . of foreign–trade zones in ports of entry of the United States, to expedite and encourage foreign commerce, and for other purposes,’’ and authorizes the Foreign–Trade Zones Board to grant to qualified corporations the privilege of establishing foreign–trade zones in or adjacent to U.S. Customs ports of entry; Whereas, the Board’s regulations (15 CFR Part 400) provide for the establishment of special–purpose subzones when existing zone facilities cannot serve the specific use involved, and when the activity results in a significant public benefit and is in the public interest; Whereas, the Puerto Rico Industrial Development Corporation, grantee of FTZ 7, has made application to the Board for authority to establish special– purpose subzone status at the pharmaceutical intermediate manufacturing plant of Ortho Biologics, ´ LLC (OBI) in Manatı, Puerto Rico (FTZ Docket 53–2004, filed 11–19–04). Whereas, notice inviting public comment has been given in the Federal Register (69 FR 70121, 12/02/04); and, Whereas, the Board adopts the findings and recommendations of the examiner’s report, and finds that the requirements of the FTZ Act and the Board’s regulations are satisfied, and that approval of the application is in the public interest; Now, therefore, the Board hereby grants authority for subzone status for activity related to pharmaceutical PO 00000 Frm 00023 Fmt 4703 Joseph A. Spetrini, Acting Assistant Secretary of Commerce for Import Administration, Alternate Chairman, Foreign–Trade Zones Board. Attest: Dennis Puccinelli, Executive Secretary. [FR Doc. 05–16401 Filed 8–17–05; 8:45 am] Sfmt 4703 DEPARTMENT OF COMMERCE Foreign–Trade Zones Board [Order No. 1407] Expansion of Foreign–Trade Zone 167, Green Bay, Wisconsin Pursuant to its authority under the Foreign–Trade Zones Act of June 18, 1934, as amended (19 U.S.C. 81a–81u), the Foreign– Trade Zones Board (the Board) adopts the following Order: Whereas, the County of Brown, Wisconsin, grantee of Foreign–Trade Zone 167, submitted an application to the Board for authority to expand FTZ 167–Site 1 to include additional parcels in Brown County and to expand the zone to include a site (1,617 acres, Site 2) in Winnebago County, Wisconsin, within the Green Bay Customs port of entry (FTZ Docket 51–2004; filed 11/12/ 04); Whereas, notice inviting public comment was given in the Federal Register (69 FR 67699, 11/19/04; 69 FR 70122, 12/2/04) and the application has been processed pursuant to the FTZ Act and the Board’s regulations; and, Whereas, the Board adopts the findings and recommendations of the examiner’s report, and finds that the requirements of the FTZ Act and Board’s regulations are satisfied, and that the proposal is in the public interest; Now, therefore, the Board hereby orders: The application to expand FTZ 167 is approved, subject to the Act and the Board’s regulations, including Section 400.28, and further subject to the Board’s standard 2,000–acre activation limit for the overall zone project. E:\FR\FM\18AUN1.SGM 18AUN1

Agencies

[Federal Register Volume 70, Number 159 (Thursday, August 18, 2005)]
[Notices]
[Page 48537]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-16401]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Order No. 1405]


Grant Of Authority For Subzone Status, Ortho Biologics, LLC, 
(Pharmaceutical Intermediates), Manat[iacute], Puerto Rico

    Pursuant to its authority under the Foreign-Trade Zones Act of 
June 18, 1934, as amended (19 U.S.C. 81a-81u), the Foreign-Trade 
Zones Board (the Board) adopts the following Order:
    Whereas, the Foreign-Trade Zones Act provides for `` . . . the 
establishment . . . of foreign-trade zones in ports of entry of the 
United States, to expedite and encourage foreign commerce, and for 
other purposes,'' and authorizes the Foreign-Trade Zones Board to grant 
to qualified corporations the privilege of establishing foreign-trade 
zones in or adjacent to U.S. Customs ports of entry;
    Whereas, the Board's regulations (15 CFR Part 400) provide for the 
establishment of special-purpose subzones when existing zone facilities 
cannot serve the specific use involved, and when the activity results 
in a significant public benefit and is in the public interest;
    Whereas, the Puerto Rico Industrial Development Corporation, 
grantee of FTZ 7, has made application to the Board for authority to 
establish special-purpose subzone status at the pharmaceutical 
intermediate manufacturing plant of Ortho Biologics, LLC (OBI) in 
Manat[iacute], Puerto Rico (FTZ Docket 53-2004, filed 11-19-04).
    Whereas, notice inviting public comment has been given in the 
Federal Register (69 FR 70121, 12/02/04); and,
    Whereas, the Board adopts the findings and recommendations of the 
examiner's report, and finds that the requirements of the FTZ Act and 
the Board's regulations are satisfied, and that approval of the 
application is in the public interest;
    Now, therefore, the Board hereby grants authority for subzone 
status for activity related to pharmaceutical intermediates at the 
manufacturing plant of Ortho Biologics, LLC, located in Manat[iacute], 
Puerto Rico (Subzone 7H), as described in the application and Federal 
Register notice, and subject to the FTZ Act and the Board's 
regulations, including Sec.  400.28.
    Signed at Washington, DC, this 4th day of August 2005.

Joseph A. Spetrini,
Acting Assistant Secretary of Commerce for Import Administration, 
Alternate Chairman, Foreign-Trade Zones Board.
    Attest:
Dennis Puccinelli,
Executive Secretary.
[FR Doc. 05-16401 Filed 8-17-05; 8:45 am]
BILLING CODE 3510-DS-S